Replimune Reports Q4 & FY2026 Results, Provides Business Update

Key Facts

1Replimune Group reported financial results for fiscal fourth quarter and year ended March 31, 2026, and provided a business update.

Replimune Group (REPL) reported its financial results for the fiscal fourth quarter and year ended March 31, 2026, and provided a business update, according to the press release. The announcement did not disclose specific revenue or loss figures, making it a routine update for investors.

The news comes after REPL stock closed at $11.63 on Friday, June 26, 2026, with the day's range between $9.88 and $11.73. Clinical-stage biotech stocks often experience sharp volatility around earnings dates, but this particular release lacked immediate catalysts beyond the operational update.